Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets
St. Jude found 156 potential targets for chimeric antigen receptor (CAR) T–cell immunotherapy. Explore the discovery’s promise to improve cancer therapies.
Read Original Article: Pan-cancer analysis uncovers a new class of promising CAR T–cell immunotherapy targets »
